New Triple Therapy in Newly Diagnosed Type 2 Diabetes

NCT06946628 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

296

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus

Interventions

DRUG: Group A (triple combination therapy group)
DRUG: Group B (standard therapy group)

Sponsor

Sun Yat-sen University